Psychosis Related Content

Presented by Dost Ӧngür, MD, PhD , and W. Brad Ruzicka, MD, PhD , McLean Hospital – Crossroads in Psychiatry lecture

Presented by Robert K. Heinssen, PhD, ABPP, National Institute of Mental Health – Visiting Scholar Series “Something remarkable has happened in the treatment of youth with early psychosis,” says Robert K. Heinssen, PhD, ABPP. Between 2008 and 2018, evidence-based first episode psychosis treatment...

Presented by Tyrone D. Cannon, PhD, Yale University – Visiting Scholar Series Currently, clinicians can use interventions that can target the symptoms and functional impairments associated with psychosis. Yet, many clinicians and researchers are working on ways to prevent psychosis or address...

Presented by Lauren V. Moran, MD, McLean Hospital – McLean Forum lecture The use of stimulants like methylphenidate, such as Ritalin, and amphetamine, including Adderall, to treat attention-deficit/hyperactivity disorder (ADHD) has been increasing. In fact, prescribing of amphetamines has risen four...

Presented by Bruce M. Cohen, MD, PhD , and Dost Öngür, MD, PhD , McLean Hospital – Crossroads in Psychiatry lecture Psychotic disorders are affected by many interacting factors. In fact, large-scale studies conducted on tens of thousands of people with genetic disorders have shown that genetic...

Cheryl Corcoran, MD, is a graduate of Harvard College and Harvard Medical School. She is an associate professor of Psychiatry and program leader in Psychosis Risk at the Icahn School of Medicine at Mount Sinai. Together with Dr. Guillermo Cecchi of IBM, Dr. Corcoran has identified linguistic...

SIRT2 as Key Regulator of Metabolic Transition During Human Induced Pluripotency Young Cha, PhD , Molecular Neurobiology Laboratory, McLean Hospital Insulin Signaling and Brain Energy Metabolism in First Episode Psychosis and Unaffected Siblings Virginie-Anne Chouinard, MD , McLean OnTrack, McLean...

Laura Tully, PhD, is an assistant professor in psychiatry at UC Davis and director of Clinical Training at the UC Davis Early Psychosis Programs. Dr. Tully received her PhD from Harvard University, completed her post-doc at UC Davis, and transitioned to faculty in 2015. Dr. Tully has expertise in...